Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes. [electronic resource]
Producer: 20090219Description: 46-58 p. digitalISSN:- 1941-9260
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Female
- Glucagon-Like Peptide-1 Receptor
- Glucose -- metabolism
- Humans
- Hypoglycemic Agents -- pharmacology
- Incretins -- pharmacology
- Insulin -- metabolism
- Insulin Secretion
- Islets of Langerhans -- drug effects
- Male
- Receptors, Glucagon -- agonists
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.